TrialJournal of translational medicine2025

Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial.

Jenny Bulgarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.